@article{ATM32541,
author = {Xiaoxia Chen and Chunxia Su and Shengxiang Ren and Caicun Zhou and Tao Jiang},
title = {Pan-cancer analysis of KEAP1 mutations as biomarkers for immunotherapy outcomes},
journal = {Annals of Translational Medicine},
volume = {8},
number = {4},
year = {2019},
keywords = {},
abstract = {Immune checkpoint inhibitors (ICIs) that target programmed cell death protein 1 (PD-1) and its ligand (PD-L1), or cytotoxic T lymphocyte antigen-4 (CTLA-4) elicit durable antitumor responses in multiple cancer types. Yet, only a minority of patients could derive clinical benefit (1).},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/32541}
}